Ibemere SO, Oyedeji CI, Preiss L, Van Althuis LE, Hankins JS, Azul M, Burns EN, Glassberg J, Hagar W, Hussain F, King A, Melvin C, Myers J, Snyder A, Shah N, Tanabe P, Sickle Cell Disease Implementation Consortium. Characterising the prevalence of overweight and obese status among adults with sickle cell disease. Br J Haematol. 2023 Mar;200(5):633-642 PMID: 36382420 PMCID: PMC9957798 SCOPUS ID: 2-s2.0-85142233570 11/17/2022
Penkert RR, Azul M, Sealy RE, Jones BG, Dowdy J, Hayden RT, Tang L, Ross AC, Hankins JS, Hurwitz JL. Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19. Nutrients. 2022 Aug 19;14(16) PMID: 36014920 PMCID: PMC9414848 SCOPUS ID: 2-s2.0-85136628826 08/27/2022
Azul M, Vital EF, Lam WA, Wood DK, Beckman JD. Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease. Transl Res. 2022 Aug;246:1-14 PMID: 35354090 PMCID: PMC9218997 SCOPUS ID: 2-s2.0-85131651108 03/31/2022
Geisness AC, Azul M, Williams D, Szafraniec H, De Souza DC, Higgins JM, Wood DK. Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease. Haematologica. 2022 Jun 01;107(6):1438-1447 PMID: 34706495 PMCID: PMC9152977 SCOPUS ID: 2-s2.0-85131219304 10/29/2021
Azul M, Shah S, Williams S, Vercellotti GM, Boucher AA. Evidence for complement-mediated bone marrow necrosis in a young adult with sickle cell disease. Blood Cells Mol Dis. 2021 Feb;86:102508 PMID: 33096468 PMCID: PMC7546691 SCOPUS ID: 2-s2.0-85093666667 10/24/2020
Azul M, Hsu L, Krepel A, Sales JM, Porto I, Hammamieh M. Letter to the Editor: A Quality Improvement Initiative for Pediatric Resident Education in Venous Thromboembolism Risk Assessment in Pediatric Patients. Am J Med Qual. 2020;35(4):359-360 PMID: 31581788 SCOPUS ID: 2-s2.0-85089129316 10/05/2019